Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety of avelumab and AVB-S6-500 and see
what effects (good and bad) this combination treatment has on patients with advanced
urothelial carcinoma.